

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.10745749 |
| 2 | immunoglobulin mediated immune response (GO:0016064) | 4.67150577 |
| 3 | positive regulation of antigen processing and presentation (GO:0002579) | 4.63296755 |
| 4 | regulation of antigen processing and presentation (GO:0002577) | 4.50106075 |
| 5 | regulation of cellular extravasation (GO:0002691) | 4.17231130 |
| 6 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.16380070 |
| 7 | regulation of guanylate cyclase activity (GO:0031282) | 4.02614496 |
| 8 | DNA deamination (GO:0045006) | 3.99159061 |
| 9 | L-fucose catabolic process (GO:0042355) | 3.83711243 |
| 10 | fucose catabolic process (GO:0019317) | 3.83711243 |
| 11 | L-fucose metabolic process (GO:0042354) | 3.83711243 |
| 12 | B cell mediated immunity (GO:0019724) | 3.81802339 |
| 13 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.81703860 |
| 14 | ATP synthesis coupled proton transport (GO:0015986) | 3.81703860 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.64927963 |
| 16 | antibacterial humoral response (GO:0019731) | 3.54897243 |
| 17 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.47212378 |
| 18 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.46866184 |
| 19 | tryptophan catabolic process (GO:0006569) | 3.45216297 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 3.45216297 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 3.45216297 |
| 22 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.39514198 |
| 23 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.38423146 |
| 24 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.38282302 |
| 25 | kynurenine metabolic process (GO:0070189) | 3.36243221 |
| 26 | antimicrobial humoral response (GO:0019730) | 3.35259647 |
| 27 | positive regulation of prostaglandin secretion (GO:0032308) | 3.29362621 |
| 28 | positive thymic T cell selection (GO:0045059) | 3.24035140 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.20134241 |
| 30 | positive regulation of respiratory burst (GO:0060267) | 3.16351739 |
| 31 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.16072052 |
| 32 | cytidine deamination (GO:0009972) | 3.15414330 |
| 33 | cytidine metabolic process (GO:0046087) | 3.15414330 |
| 34 | cytidine catabolic process (GO:0006216) | 3.15414330 |
| 35 | angiotensin maturation (GO:0002003) | 3.14784231 |
| 36 | tryptophan metabolic process (GO:0006568) | 3.09527716 |
| 37 | ribosomal small subunit assembly (GO:0000028) | 3.07224071 |
| 38 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.03424241 |
| 39 | respiratory chain complex IV assembly (GO:0008535) | 3.03254134 |
| 40 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.01789877 |
| 41 | indolalkylamine metabolic process (GO:0006586) | 2.94025503 |
| 42 | lymphocyte costimulation (GO:0031294) | 2.92400251 |
| 43 | T cell costimulation (GO:0031295) | 2.91662533 |
| 44 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.91415229 |
| 45 | GPI anchor biosynthetic process (GO:0006506) | 2.90378074 |
| 46 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.88662728 |
| 47 | NADH metabolic process (GO:0006734) | 2.88231012 |
| 48 | sulfation (GO:0051923) | 2.87030560 |
| 49 | drug catabolic process (GO:0042737) | 2.83265344 |
| 50 | electron transport chain (GO:0022900) | 2.80443394 |
| 51 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.78947884 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 2.77858582 |
| 53 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.77630446 |
| 54 | regulation of cGMP biosynthetic process (GO:0030826) | 2.77142632 |
| 55 | respiratory electron transport chain (GO:0022904) | 2.75329536 |
| 56 | regulation of regulatory T cell differentiation (GO:0045589) | 2.74825514 |
| 57 | viral transcription (GO:0019083) | 2.74648253 |
| 58 | GPI anchor metabolic process (GO:0006505) | 2.74171862 |
| 59 | cytochrome complex assembly (GO:0017004) | 2.73291351 |
| 60 | exogenous drug catabolic process (GO:0042738) | 2.71793783 |
| 61 | vitamin biosynthetic process (GO:0009110) | 2.69705811 |
| 62 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.69363355 |
| 63 | mannosylation (GO:0097502) | 2.66633738 |
| 64 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 2.65995101 |
| 65 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.65572678 |
| 66 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.63688820 |
| 67 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.60905482 |
| 68 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.57811056 |
| 69 | arginine metabolic process (GO:0006525) | 2.56795164 |
| 70 | response to interferon-beta (GO:0035456) | 2.56059132 |
| 71 | xenobiotic catabolic process (GO:0042178) | 2.54034742 |
| 72 | translational termination (GO:0006415) | 2.53650523 |
| 73 | regulation of prostaglandin secretion (GO:0032306) | 2.52453020 |
| 74 | killing of cells of other organism (GO:0031640) | 2.51367233 |
| 75 | disruption of cells of other organism (GO:0044364) | 2.51367233 |
| 76 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.48339686 |
| 77 | positive regulation of neutrophil migration (GO:1902624) | 2.48339686 |
| 78 | regulation of immunoglobulin secretion (GO:0051023) | 2.48042681 |
| 79 | positive regulation of activated T cell proliferation (GO:0042104) | 2.48030050 |
| 80 | cellular response to interferon-beta (GO:0035458) | 2.48019323 |
| 81 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.46776935 |
| 82 | positive regulation of fatty acid transport (GO:2000193) | 2.44697885 |
| 83 | positive regulation of T cell migration (GO:2000406) | 2.44575896 |
| 84 | T-helper 1 type immune response (GO:0042088) | 2.41460767 |
| 85 | proton transport (GO:0015992) | 2.40849862 |
| 86 | protein targeting to ER (GO:0045047) | 2.40647700 |
| 87 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.40518509 |
| 88 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.39872961 |
| 89 | fucosylation (GO:0036065) | 2.39838985 |
| 90 | dendritic cell chemotaxis (GO:0002407) | 2.39655657 |
| 91 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.39314613 |
| 92 | cotranslational protein targeting to membrane (GO:0006613) | 2.39304439 |
| 93 | translational elongation (GO:0006414) | 2.38449858 |
| 94 | hydrogen transport (GO:0006818) | 2.38300860 |
| 95 | cellular response to interferon-gamma (GO:0071346) | 2.36983222 |
| 96 | positive regulation of icosanoid secretion (GO:0032305) | 2.36718336 |
| 97 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.35775361 |
| 98 | positive T cell selection (GO:0043368) | 2.35382692 |
| 99 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.35184513 |
| 100 | negative regulation of leukocyte migration (GO:0002686) | 2.34735801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.44390682 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.11170081 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.02970238 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.30560272 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 3.11793757 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.85412104 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.80792664 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.54619161 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.50007607 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.42346172 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.23925744 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.20122953 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.92863042 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.84783651 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.84218672 |
| 16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.83191827 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.81977459 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.80417179 |
| 19 | GATA3_26560356_Chip-Seq_TH2_Human | 1.77648269 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.76415167 |
| 21 | AR_20517297_ChIP-Seq_VCAP_Human | 1.58285035 |
| 22 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.57590017 |
| 23 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.55677630 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.52686201 |
| 25 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.52003309 |
| 26 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.51749144 |
| 27 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.50943714 |
| 28 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.50943714 |
| 29 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.49576404 |
| 30 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.49052339 |
| 31 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.49047354 |
| 32 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.44577393 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40606828 |
| 34 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40146892 |
| 35 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.39919873 |
| 36 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.38866793 |
| 37 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.36044302 |
| 38 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.35904488 |
| 39 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.34701539 |
| 40 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.34568694 |
| 41 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.34568694 |
| 42 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.33659412 |
| 43 | P300_27268052_Chip-Seq_Bcells_Human | 1.32502421 |
| 44 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.32402560 |
| 45 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.31703602 |
| 46 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.31126547 |
| 47 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.31069393 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.29671385 |
| 49 | MYB_26560356_Chip-Seq_TH2_Human | 1.29497748 |
| 50 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.29400402 |
| 51 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.28582256 |
| 52 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.28577881 |
| 53 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.27999780 |
| 54 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.26989738 |
| 55 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26758650 |
| 56 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.25807443 |
| 57 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25693739 |
| 58 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.24445898 |
| 59 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.24265098 |
| 60 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.23757161 |
| 61 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.21251057 |
| 62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.20693569 |
| 63 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.20199655 |
| 64 | NCOR_22424771_ChIP-Seq_293T_Human | 1.19738354 |
| 65 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.19712456 |
| 66 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.18226373 |
| 67 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.17749804 |
| 68 | ERA_21632823_ChIP-Seq_H3396_Human | 1.17714975 |
| 69 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.15651627 |
| 70 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.15091166 |
| 71 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.14657020 |
| 72 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13805002 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12927387 |
| 74 | EWS_26573619_Chip-Seq_HEK293_Human | 1.12754233 |
| 75 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.12426000 |
| 76 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.12088769 |
| 77 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.11036169 |
| 78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10522602 |
| 79 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10311958 |
| 80 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.10226397 |
| 81 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09495166 |
| 82 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.09387601 |
| 83 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.07904613 |
| 84 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07733156 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07260917 |
| 86 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05912511 |
| 87 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.03482321 |
| 88 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.02864429 |
| 89 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02740392 |
| 90 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02323164 |
| 91 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.01910179 |
| 92 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.00676919 |
| 93 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.99941876 |
| 94 | FUS_26573619_Chip-Seq_HEK293_Human | 0.99678564 |
| 95 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.99214424 |
| 96 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.99069658 |
| 97 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.97610899 |
| 98 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.97557596 |
| 99 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96615496 |
| 100 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.95974127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.04301307 |
| 2 | MP0005360_urolithiasis | 3.72193279 |
| 3 | MP0002138_abnormal_hepatobiliary_system | 3.67160603 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.26908393 |
| 5 | MP0009379_abnormal_foot_pigmentation | 3.17702011 |
| 6 | MP0005671_abnormal_response_to | 3.02188030 |
| 7 | MP0000685_abnormal_immune_system | 2.67262185 |
| 8 | MP0004147_increased_porphyrin_level | 2.53037822 |
| 9 | MP0010155_abnormal_intestine_physiology | 2.48758891 |
| 10 | MP0003724_increased_susceptibility_to | 2.45183232 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.38585632 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.23201610 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.16809933 |
| 14 | MP0001800_abnormal_humoral_immune | 2.15950146 |
| 15 | MP0001873_stomach_inflammation | 2.14251303 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.08646584 |
| 17 | MP0001790_abnormal_immune_system | 2.07442355 |
| 18 | MP0005387_immune_system_phenotype | 2.07442355 |
| 19 | MP0001666_abnormal_nutrient_absorption | 1.97205436 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.93070001 |
| 21 | MP0008872_abnormal_physiological_respon | 1.91679138 |
| 22 | MP0009764_decreased_sensitivity_to | 1.85448179 |
| 23 | MP0009785_altered_susceptibility_to | 1.82692196 |
| 24 | MP0003866_abnormal_defecation | 1.82099142 |
| 25 | MP0002876_abnormal_thyroid_physiology | 1.77119474 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 1.75901118 |
| 27 | MP0008875_abnormal_xenobiotic_pharmacok | 1.73777603 |
| 28 | MP0005645_abnormal_hypothalamus_physiol | 1.69521145 |
| 29 | MP0003718_maternal_effect | 1.65217995 |
| 30 | MP0002723_abnormal_immune_serum | 1.64434762 |
| 31 | MP0003436_decreased_susceptibility_to | 1.64328697 |
| 32 | MP0002006_tumorigenesis | 1.60922009 |
| 33 | MP0008775_abnormal_heart_ventricle | 1.58668461 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.57424892 |
| 35 | MP0003252_abnormal_bile_duct | 1.55922546 |
| 36 | MP0003646_muscle_fatigue | 1.51932843 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.47952576 |
| 38 | MP0001819_abnormal_immune_cell | 1.46835920 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.45568865 |
| 40 | MP0001986_abnormal_taste_sensitivity | 1.45437228 |
| 41 | MP0003195_calcinosis | 1.41313784 |
| 42 | MP0005332_abnormal_amino_acid | 1.41154015 |
| 43 | MP0005365_abnormal_bile_salt | 1.38497420 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 1.36759209 |
| 45 | MP0001663_abnormal_digestive_system | 1.35969113 |
| 46 | MP0005025_abnormal_response_to | 1.34553368 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.31714523 |
| 48 | MP0009643_abnormal_urine_homeostasis | 1.30504650 |
| 49 | MP0005166_decreased_susceptibility_to | 1.30105609 |
| 50 | MP0006072_abnormal_retinal_apoptosis | 1.28742224 |
| 51 | MP0003763_abnormal_thymus_physiology | 1.27419628 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.25448884 |
| 53 | MP0008877_abnormal_DNA_methylation | 1.23406677 |
| 54 | MP0002102_abnormal_ear_morphology | 1.23380230 |
| 55 | MP0010329_abnormal_lipoprotein_level | 1.19154454 |
| 56 | MP0001765_abnormal_ion_homeostasis | 1.17461472 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.09529972 |
| 58 | MP0001764_abnormal_homeostasis | 1.07171364 |
| 59 | MP0008469_abnormal_protein_level | 1.07030525 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.06366745 |
| 61 | MP0001501_abnormal_sleep_pattern | 1.05817391 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 1.04955136 |
| 63 | MP0000716_abnormal_immune_system | 1.03927944 |
| 64 | MP0003011_delayed_dark_adaptation | 1.03639228 |
| 65 | MP0004043_abnormal_pH_regulation | 1.03231722 |
| 66 | MP0001664_abnormal_digestion | 1.02185633 |
| 67 | MP0003303_peritoneal_inflammation | 1.00306311 |
| 68 | MP0001968_abnormal_touch/_nociception | 0.97667730 |
| 69 | MP0002837_dystrophic_cardiac_calcinosis | 0.97271656 |
| 70 | MP0005636_abnormal_mineral_homeostasis | 0.96399327 |
| 71 | MP0000372_irregular_coat_pigmentation | 0.95053557 |
| 72 | MP0000230_abnormal_systemic_arterial | 0.94886020 |
| 73 | MP0002136_abnormal_kidney_physiology | 0.92256774 |
| 74 | MP0001533_abnormal_skeleton_physiology | 0.92249489 |
| 75 | MP0000689_abnormal_spleen_morphology | 0.90584134 |
| 76 | MP0005381_digestive/alimentary_phenotyp | 0.90285511 |
| 77 | MP0002398_abnormal_bone_marrow | 0.89134162 |
| 78 | MP0003638_abnormal_response/metabolism_ | 0.88733048 |
| 79 | MP0002419_abnormal_innate_immunity | 0.88474725 |
| 80 | MP0004885_abnormal_endolymph | 0.87431997 |
| 81 | MP0005551_abnormal_eye_electrophysiolog | 0.87135540 |
| 82 | MP0000013_abnormal_adipose_tissue | 0.86752068 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 0.86669336 |
| 84 | MP0000490_abnormal_crypts_of | 0.85000140 |
| 85 | MP0000538_abnormal_urinary_bladder | 0.83292862 |
| 86 | MP0000516_abnormal_urinary_system | 0.82875143 |
| 87 | MP0005367_renal/urinary_system_phenotyp | 0.82875143 |
| 88 | MP0001756_abnormal_urination | 0.82063319 |
| 89 | MP0002429_abnormal_blood_cell | 0.79095101 |
| 90 | MP0003786_premature_aging | 0.77578917 |
| 91 | MP0006082_CNS_inflammation | 0.77405700 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.76028703 |
| 93 | MP0001905_abnormal_dopamine_level | 0.75520595 |
| 94 | MP0002405_respiratory_system_inflammati | 0.74011239 |
| 95 | MP0000427_abnormal_hair_cycle | 0.73423957 |
| 96 | MP0001919_abnormal_reproductive_system | 0.71344239 |
| 97 | MP0000477_abnormal_intestine_morphology | 0.70926354 |
| 98 | MP0002736_abnormal_nociception_after | 0.70542143 |
| 99 | MP0005646_abnormal_pituitary_gland | 0.69366004 |
| 100 | MP0005448_abnormal_energy_balance | 0.68877206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.00061921 |
| 2 | Chronic diarrhea (HP:0002028) | 3.74669218 |
| 3 | Congenital, generalized hypertrichosis (HP:0004540) | 3.69246979 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.36920730 |
| 5 | IgG deficiency (HP:0004315) | 3.31039338 |
| 6 | Lipid accumulation in hepatocytes (HP:0006561) | 3.16559734 |
| 7 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.15622746 |
| 8 | Mitochondrial inheritance (HP:0001427) | 3.11950277 |
| 9 | Acute necrotizing encephalopathy (HP:0006965) | 3.05017061 |
| 10 | Abnormality of vitamin B metabolism (HP:0004340) | 2.98325249 |
| 11 | Glycosuria (HP:0003076) | 2.91953922 |
| 12 | Abnormality of urine glucose concentration (HP:0011016) | 2.91953922 |
| 13 | Abnormality of B cell number (HP:0010975) | 2.89853364 |
| 14 | Hydroxyprolinuria (HP:0003080) | 2.86642476 |
| 15 | Abnormality of proline metabolism (HP:0010907) | 2.86642476 |
| 16 | Abnormality of the prostate (HP:0008775) | 2.86307717 |
| 17 | Acute encephalopathy (HP:0006846) | 2.85398224 |
| 18 | Agammaglobulinemia (HP:0004432) | 2.84405617 |
| 19 | Increased CSF lactate (HP:0002490) | 2.83548538 |
| 20 | Hepatocellular necrosis (HP:0001404) | 2.81733810 |
| 21 | Abnormality of T cell physiology (HP:0011840) | 2.75828183 |
| 22 | Methylmalonic aciduria (HP:0012120) | 2.74461465 |
| 23 | Hepatic necrosis (HP:0002605) | 2.72697561 |
| 24 | Increased hepatocellular lipid droplets (HP:0006565) | 2.70423586 |
| 25 | Progressive macrocephaly (HP:0004481) | 2.69424289 |
| 26 | Congenital stationary night blindness (HP:0007642) | 2.68608709 |
| 27 | Lethargy (HP:0001254) | 2.64977653 |
| 28 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.63189837 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 2.62239648 |
| 30 | Abolished electroretinogram (ERG) (HP:0000550) | 2.59667009 |
| 31 | Nausea (HP:0002018) | 2.53799096 |
| 32 | Stomatitis (HP:0010280) | 2.51662489 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.51178365 |
| 34 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.50419377 |
| 35 | Dicarboxylic aciduria (HP:0003215) | 2.50419377 |
| 36 | Hyperglycinuria (HP:0003108) | 2.47850576 |
| 37 | Stomach cancer (HP:0012126) | 2.44381966 |
| 38 | Alkalosis (HP:0001948) | 2.38628628 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 2.37189394 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.37189394 |
| 41 | Metabolic alkalosis (HP:0200114) | 2.34300206 |
| 42 | 3-Methylglutaconic aciduria (HP:0003535) | 2.33826143 |
| 43 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.33660955 |
| 44 | Methylmalonic acidemia (HP:0002912) | 2.31532543 |
| 45 | Decreased circulating renin level (HP:0003351) | 2.29778359 |
| 46 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.29529316 |
| 47 | Abnormality of T cells (HP:0002843) | 2.28793224 |
| 48 | Vasculitis (HP:0002633) | 2.27080418 |
| 49 | Cerebral edema (HP:0002181) | 2.26131630 |
| 50 | Lactic acidosis (HP:0003128) | 2.25931887 |
| 51 | Pigmentary retinal degeneration (HP:0001146) | 2.24010551 |
| 52 | Congenital sensorineural hearing impairment (HP:0008527) | 2.21813378 |
| 53 | Increased muscle lipid content (HP:0009058) | 2.18137969 |
| 54 | Renal Fanconi syndrome (HP:0001994) | 2.16492854 |
| 55 | Pustule (HP:0200039) | 2.15598115 |
| 56 | Delayed CNS myelination (HP:0002188) | 2.14628592 |
| 57 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.14597475 |
| 58 | B lymphocytopenia (HP:0010976) | 2.14459886 |
| 59 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.11680935 |
| 60 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.11680935 |
| 61 | Hyperphosphaturia (HP:0003109) | 2.11271919 |
| 62 | Hypoproteinemia (HP:0003075) | 2.11248146 |
| 63 | Pulmonary infiltrates (HP:0002113) | 2.10944574 |
| 64 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.10022604 |
| 65 | Increased serum lactate (HP:0002151) | 2.09713708 |
| 66 | Systemic lupus erythematosus (HP:0002725) | 2.09418374 |
| 67 | Hypothermia (HP:0002045) | 2.07624881 |
| 68 | Increased IgM level (HP:0003496) | 2.07262008 |
| 69 | Malnutrition (HP:0004395) | 2.06579326 |
| 70 | Metabolic acidosis (HP:0001942) | 2.05632830 |
| 71 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.05373204 |
| 72 | Meningitis (HP:0001287) | 2.03802210 |
| 73 | Abnormality of magnesium homeostasis (HP:0004921) | 2.03447606 |
| 74 | Exertional dyspnea (HP:0002875) | 2.01993355 |
| 75 | Facial diplegia (HP:0001349) | 2.01854650 |
| 76 | Pancreatitis (HP:0001733) | 2.01519110 |
| 77 | Recurrent bronchitis (HP:0002837) | 2.00846137 |
| 78 | Myositis (HP:0100614) | 2.00652943 |
| 79 | Abnormal number of erythroid precursors (HP:0012131) | 1.97544016 |
| 80 | Abnormality of the renal cortex (HP:0011035) | 1.96099455 |
| 81 | Increased intramyocellular lipid droplets (HP:0012240) | 1.93898738 |
| 82 | Type 2 muscle fiber atrophy (HP:0003554) | 1.93862605 |
| 83 | Macrocytic anemia (HP:0001972) | 1.93598442 |
| 84 | Pancreatic cysts (HP:0001737) | 1.92394302 |
| 85 | Facial shape deformation (HP:0011334) | 1.91935614 |
| 86 | Potter facies (HP:0002009) | 1.91935614 |
| 87 | Optic disc pallor (HP:0000543) | 1.90934075 |
| 88 | Hyperglycinemia (HP:0002154) | 1.89617596 |
| 89 | Hemoptysis (HP:0002105) | 1.89575180 |
| 90 | Abnormality of vitamin metabolism (HP:0100508) | 1.89354243 |
| 91 | Respiratory failure (HP:0002878) | 1.87342427 |
| 92 | Hypoalbuminemia (HP:0003073) | 1.86634112 |
| 93 | Abnormal albumin level (HP:0012116) | 1.86634112 |
| 94 | Chronic otitis media (HP:0000389) | 1.83904771 |
| 95 | Abnormal drinking behavior (HP:0030082) | 1.81611251 |
| 96 | Polydipsia (HP:0001959) | 1.81611251 |
| 97 | IgM deficiency (HP:0002850) | 1.81052368 |
| 98 | Abnormal urine output (HP:0012590) | 1.80015402 |
| 99 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.78645119 |
| 100 | Cerebral palsy (HP:0100021) | 1.78514167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 3.11185037 |
| 2 | MAP4K2 | 3.02590299 |
| 3 | MAP4K1 | 2.99131760 |
| 4 | ZAK | 2.97462459 |
| 5 | ACVR1B | 2.95761751 |
| 6 | ADRBK2 | 2.90085268 |
| 7 | TXK | 2.78475071 |
| 8 | FRK | 2.52890746 |
| 9 | TAOK3 | 2.40112133 |
| 10 | GRK1 | 2.33180494 |
| 11 | KIT | 2.31388009 |
| 12 | TIE1 | 2.24276052 |
| 13 | NUAK1 | 2.12639055 |
| 14 | TEC | 1.86048254 |
| 15 | MAP2K2 | 1.82435790 |
| 16 | MST4 | 1.67358469 |
| 17 | WNK4 | 1.65182470 |
| 18 | MAP3K12 | 1.64652174 |
| 19 | CDK8 | 1.64249730 |
| 20 | CDK19 | 1.58721122 |
| 21 | SYK | 1.58621492 |
| 22 | OXSR1 | 1.56702764 |
| 23 | GRK6 | 1.54239621 |
| 24 | ERN1 | 1.47829279 |
| 25 | EIF2AK3 | 1.47711183 |
| 26 | VRK2 | 1.41202269 |
| 27 | IKBKE | 1.35402870 |
| 28 | FES | 1.35043773 |
| 29 | ITK | 1.32114005 |
| 30 | STK39 | 1.30164774 |
| 31 | IKBKB | 1.26803842 |
| 32 | STK16 | 1.24917158 |
| 33 | RIPK4 | 1.22047451 |
| 34 | CSF1R | 1.20474637 |
| 35 | BCKDK | 1.19085782 |
| 36 | MYLK | 1.13699759 |
| 37 | TBK1 | 1.12442682 |
| 38 | KDR | 1.12329160 |
| 39 | BMPR2 | 1.11404359 |
| 40 | LYN | 1.10931675 |
| 41 | BMPR1B | 1.07896581 |
| 42 | MAPKAPK3 | 1.05187354 |
| 43 | WNK3 | 1.04810322 |
| 44 | PINK1 | 1.00379289 |
| 45 | NEK1 | 1.00091787 |
| 46 | PHKG1 | 0.99080042 |
| 47 | PHKG2 | 0.99080042 |
| 48 | JAK3 | 0.98664597 |
| 49 | BTK | 0.97547447 |
| 50 | DAPK2 | 0.89826536 |
| 51 | MAP2K6 | 0.88443991 |
| 52 | RPS6KA5 | 0.84702622 |
| 53 | TRIM28 | 0.84102996 |
| 54 | MKNK1 | 0.83640964 |
| 55 | MATK | 0.82826837 |
| 56 | PASK | 0.82704622 |
| 57 | PDK2 | 0.81725615 |
| 58 | TESK2 | 0.80581820 |
| 59 | LCK | 0.79988216 |
| 60 | MAPKAPK5 | 0.75048424 |
| 61 | INSRR | 0.74951901 |
| 62 | PLK4 | 0.73477206 |
| 63 | PRKCQ | 0.72255667 |
| 64 | ERBB3 | 0.71995617 |
| 65 | ADRBK1 | 0.71620659 |
| 66 | MAP3K14 | 0.71056268 |
| 67 | VRK1 | 0.67275340 |
| 68 | DYRK2 | 0.63996256 |
| 69 | PLK2 | 0.63421061 |
| 70 | TNK2 | 0.60723479 |
| 71 | PRKG2 | 0.57946445 |
| 72 | IGF1R | 0.56203378 |
| 73 | ABL1 | 0.54471807 |
| 74 | DAPK1 | 0.54061164 |
| 75 | PRKCA | 0.53998894 |
| 76 | CSNK1G3 | 0.53890405 |
| 77 | PIK3CA | 0.51491450 |
| 78 | FLT3 | 0.47053037 |
| 79 | SCYL2 | 0.45823426 |
| 80 | HCK | 0.44497436 |
| 81 | MAPK13 | 0.42524148 |
| 82 | TYK2 | 0.41372136 |
| 83 | PIM1 | 0.41274900 |
| 84 | CSK | 0.41005472 |
| 85 | NLK | 0.40539517 |
| 86 | PRKCE | 0.40193647 |
| 87 | CSNK1A1 | 0.39747850 |
| 88 | GRK5 | 0.38543360 |
| 89 | MKNK2 | 0.38416017 |
| 90 | TGFBR1 | 0.38300660 |
| 91 | PRKACG | 0.37891940 |
| 92 | PRKACA | 0.37821441 |
| 93 | CSNK2A1 | 0.37315065 |
| 94 | PRKCD | 0.36886437 |
| 95 | CHUK | 0.33413203 |
| 96 | CSNK2A2 | 0.33318632 |
| 97 | ILK | 0.33248921 |
| 98 | RPS6KB2 | 0.33033677 |
| 99 | CSNK1G2 | 0.31931608 |
| 100 | DAPK3 | 0.31898863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 5.33776455 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.25621225 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 4.18525987 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.98835478 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.70874840 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.40244528 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.37605748 |
| 8 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.26789263 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.17194776 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.13791272 |
| 11 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.05319090 |
| 12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.00754450 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.90767181 |
| 14 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.87000716 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.86251671 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.82634534 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 1.78310942 |
| 18 | Proteasome_Homo sapiens_hsa03050 | 1.74509001 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.72770779 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.66526191 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.66439419 |
| 22 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.47990691 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.44933613 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.44430508 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.42911472 |
| 26 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.41832368 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.32503226 |
| 28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.22109208 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.17866252 |
| 30 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.15430697 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.14815111 |
| 32 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.97094823 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.94181611 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.90102729 |
| 35 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.89981864 |
| 36 | Protein export_Homo sapiens_hsa03060 | 0.89158579 |
| 37 | Alzheimers disease_Homo sapiens_hsa05010 | 0.89065459 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.87343435 |
| 39 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.86370847 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.84960527 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82750430 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 0.81908258 |
| 43 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.81285156 |
| 44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.79496531 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78126715 |
| 46 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74784094 |
| 47 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.74392640 |
| 48 | Mineral absorption_Homo sapiens_hsa04978 | 0.73537883 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72027882 |
| 50 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.67028545 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 0.66841790 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66581118 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.66061619 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65001950 |
| 55 | Huntingtons disease_Homo sapiens_hsa05016 | 0.63867051 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63776873 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60754144 |
| 58 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.60726288 |
| 59 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.60235511 |
| 60 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.58897045 |
| 61 | Histidine metabolism_Homo sapiens_hsa00340 | 0.57589989 |
| 62 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57077033 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52542560 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51948071 |
| 65 | Peroxisome_Homo sapiens_hsa04146 | 0.51665342 |
| 66 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.48894777 |
| 67 | RNA polymerase_Homo sapiens_hsa03020 | 0.48681095 |
| 68 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.48560891 |
| 69 | Homologous recombination_Homo sapiens_hsa03440 | 0.47481873 |
| 70 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.45993295 |
| 71 | Tuberculosis_Homo sapiens_hsa05152 | 0.45836221 |
| 72 | RNA degradation_Homo sapiens_hsa03018 | 0.44014321 |
| 73 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.43553206 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.43273197 |
| 75 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.42515305 |
| 76 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42392043 |
| 77 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.38709424 |
| 78 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.38663165 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37941749 |
| 80 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33962225 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31852372 |
| 82 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.31452414 |
| 83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.31003238 |
| 84 | Purine metabolism_Homo sapiens_hsa00230 | 0.28880335 |
| 85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27097534 |
| 86 | Phagosome_Homo sapiens_hsa04145 | 0.26095993 |
| 87 | Influenza A_Homo sapiens_hsa05164 | 0.25816902 |
| 88 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.25417440 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.24693534 |
| 90 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.22682973 |
| 91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.22333732 |
| 92 | Olfactory transduction_Homo sapiens_hsa04740 | 0.21592622 |
| 93 | Base excision repair_Homo sapiens_hsa03410 | 0.21531226 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.21220363 |
| 95 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.21150919 |
| 96 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.21089563 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20401761 |
| 98 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.19996942 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19941340 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.19392289 |

